European Commission-EFPIA innovative medicines project progresses
This article was originally published in SRA
Executive Summary
Pharmaceutical companies whose research proposals have been short-listed under the first phase of the European Union’s Innovative Medicines Initiative are being asked to submit full project proposals by 20 January1.